These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 16644777)

  • 1. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients.
    Boudville NC; Hodsman AB
    Nephrol Dial Transplant; 2006 Sep; 21(9):2621-4. PubMed ID: 16644777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?
    Lomonte C; Antonelli M; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C
    J Nephrol; 2005; 18(1):96-101. PubMed ID: 15772930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of 25-hydroxyvitamin D and its association with bone mineral density and serum parathyroid hormone levels during winter in urban males from Guiyang, Southwest China.
    Zhang Q; Shi L; Peng N; Xu S; Zhang M; Zhang S; Li H; Zhuang H; Gong M; Wu D; Wang R
    Br J Nutr; 2016 Mar; 115(6):960-6. PubMed ID: 26843386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between 25-hydroxyvitamin D concentrations, serum calcium, and parathyroid hormone in apparently healthy Syrian people.
    Sayed-Hassan R; Abazid N; Alourfi Z
    Arch Osteoporos; 2014; 9():176. PubMed ID: 24715441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A threshold value of estimated glomerular filtration rate that predicts changes in serum 25-hydroxyvitamin D levels: 4th Korean National Health and Nutritional Examination Survey 2008.
    Oh YJ; Kim M; Lee H; Lee JP; Kim H; Kim S; Oh KH; Joo KW; Lim CS; Kim S; Kim YS; Kim DK
    Nephrol Dial Transplant; 2012 Jun; 27(6):2396-403. PubMed ID: 22262736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD.
    Al-Aly Z; Qazi RA; González EA; Zeringue A; Martin KJ
    Am J Kidney Dis; 2007 Jul; 50(1):59-68. PubMed ID: 17591525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
    Ennis JL; Worcester EM; Coe FL; Sprague SM
    J Nephrol; 2016 Feb; 29(1):63-70. PubMed ID: 25736620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D status and parathyroid hormone levels in relation to bone mineral density in apparently healthy Syrian adults.
    Sayed-Hassan R; Abazid N; Koudsi A; Alourfi Z
    Arch Osteoporos; 2016; 11():18. PubMed ID: 27126333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of a single 'mega intramuscular dose' of vitamin D on serum 25OHD and parathyroid hormone levels.
    Khan AH; Rohra DK; Saghir SA; Udani SK; Wood R; Jabbar A
    J Coll Physicians Surg Pak; 2012 Apr; 22(4):207-12. PubMed ID: 22482374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum 25-hydroxyvitamin D and parathyroid hormone in the search for a biochemical definition of vitamin D deficiency in children.
    Atapattu N; Shaw N; Högler W
    Pediatr Res; 2013 Nov; 74(5):552-6. PubMed ID: 23999068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
    Caravaca F; Fernández MA; Ruiz-Calero R; Cubero J; Aparicio A; Jimenez F; García MC
    Nephrol Dial Transplant; 1998 Oct; 13(10):2605-11. PubMed ID: 9794568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients.
    Souberbielle JC; Massart C; Brailly-Tabard S; Cormier C; Cavalier E; Delanaye P; Chanson P
    Eur J Endocrinol; 2016 Mar; 174(3):315-23. PubMed ID: 26628583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal transplant and secondary hyperparathyroidism.
    Gøransson LG; Bergrem H
    Scand J Urol Nephrol; 2007; 41(6):553-7. PubMed ID: 18050015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low vitamin D levels have become less common in primary hyperparathyroidism.
    Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
    Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to normalize parathyroid hormone during treatment of vitamin D deficiency in Asian patients.
    Peacey SR; Wright D; Harries MJ
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):603-6. PubMed ID: 15521963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
    Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay-specific decision limits for two new automated parathyroid hormone and 25-hydroxyvitamin D assays.
    Souberbielle JC; Fayol V; Sault C; Lawson-Body E; Kahan A; Cormier C
    Clin Chem; 2005 Feb; 51(2):395-400. PubMed ID: 15563480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis.
    Sahota O; Mundey MK; San P; Godber IM; Lawson N; Hosking DJ
    Bone; 2004 Jul; 35(1):312-9. PubMed ID: 15207772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
    Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
    Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for secondary hyperparathyroidism in a nursing home population.
    Stein MS; Scherer SC; Walton SL; Gilbert RE; Ebeling PR; Flicker L; Wark JD
    Clin Endocrinol (Oxf); 1996 Apr; 44(4):375-83. PubMed ID: 8706303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.